Put Options

15 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$172.58 - $196.48 $5.61 Million - $6.39 Million
32,500 New
32,500 $6.35 Million
Q2 2023

Aug 03, 2023

BUY
$160.94 - $186.23 $5.73 Million - $6.63 Million
35,600 New
35,600 $6.13 Million
Q4 2020

Feb 11, 2021

SELL
$157.07 - $174.35 $15,707 - $17,435
-100 Reduced 1.41%
7,000 $1.16 Million
Q2 2020

Aug 12, 2020

SELL
$111.92 - $142.53 $1.4 Million - $1.78 Million
-12,500 Reduced 63.78%
7,100 $973,000
Q1 2020

May 13, 2020

BUY
$92.66 - $144.94 $1.18 Million - $1.84 Million
12,700 Added 184.06%
19,600 $2.31 Million
Q4 2019

Feb 10, 2020

BUY
$116.25 - $133.25 $651,000 - $746,200
5,600 Added 430.77%
6,900 $913,000
Q3 2019

Nov 14, 2019

SELL
$112.57 - $128.43 $146,341 - $166,959
-1,300 Reduced 50.0%
1,300 $162,000
Q2 2019

Aug 14, 2019

SELL
$97.98 - $114.28 $101 Million - $118 Million
-1,031,400 Reduced 99.75%
2,600 $295,000
Q1 2019

May 15, 2019

BUY
$81.56 - $100.67 $83.9 Million - $104 Million
1,029,300 Added 21900.0%
1,034,000 $104 Million
Q4 2018

Feb 14, 2019

BUY
$79.28 - $95.27 $103,064 - $123,851
1,300 Added 38.24%
4,700 $402,000
Q3 2018

Nov 14, 2018

SELL
$83.5 - $93.23 $9.63 Million - $10.7 Million
-115,300 Reduced 97.14%
3,400 $311,000
Q2 2018

Aug 14, 2018

BUY
$79.9 - $89.2 $1.09 Million - $1.21 Million
13,600 Added 12.94%
118,700 $10.1 Million
Q1 2018

May 15, 2018

BUY
$71.51 - $84.69 $4.81 Million - $5.69 Million
67,200 Added 177.31%
105,100 $8.78 Million
Q4 2017

Feb 14, 2018

SELL
$63.24 - $72.8 $12,648 - $14,560
-200 Reduced 0.52%
37,900 $2.73 Million
Q3 2017

Nov 14, 2017

BUY
$59.73 - $65.4 $2.28 Million - $2.49 Million
38,100
38,100 $2.43 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.